The Aperio Blog
Begin With the End in Mind: Top 5 Considerations on Your Critical Path to First-in-Human Clinical Trials
You have been moving steadily from discovery into preclinical, and based on the data, your molecule will be advancing into First-in-Human clinical trials. Congratulations are in order ─ but with limited funds, tight resources, and a myriad of conflicting priorities, how do you begin to make sure your organization is ready for clinical trials?
To help you prioritize what is most important, we have summarized the top five most important considerations on your critical path to FIH clinical trials.
About Aperio Clinical Outcomes
Aperio Clinical Outcomes offers essential services for today’s complex, data-intensive oncology and rare disease clinical trials: rock-solid fit-for-purpose database development and management, unmatched analytics expertise, and powerful holistic tools that deliver the most coherent and actionable views of essential data. Just as important, in an industry flooded with promises, we make only one: We tell the truth, no matter what.
